Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 6,250.00
-130.00 (-2.04%)
Oct 31, 2025, 3:30 PM KST
Bio Plus Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Operating Revenue | 89,163 | 66,410 | 65,043 | 56,719 | 37,418 | 24,367 | Upgrade |
Other Revenue | - | -0 | - | - | - | - | Upgrade |
| 89,163 | 66,410 | 65,043 | 56,719 | 37,418 | 24,367 | Upgrade | |
Revenue Growth (YoY) | 63.36% | 2.10% | 14.68% | 51.58% | 53.56% | 43.16% | Upgrade |
Cost of Revenue | 30,179 | 23,875 | 25,525 | 22,942 | 13,790 | 7,818 | Upgrade |
Gross Profit | 58,984 | 42,535 | 39,518 | 33,776 | 23,628 | 16,549 | Upgrade |
Selling, General & Admin | 24,357 | 14,172 | 8,170 | 6,534 | 4,339 | 2,719 | Upgrade |
Research & Development | 2,449 | 1,477 | 1,165 | 1,081 | 435.18 | 276.05 | Upgrade |
Amortization of Goodwill & Intangibles | 459.18 | 436.81 | 340.2 | 203.14 | 111.76 | 81.73 | Upgrade |
Other Operating Expenses | 269.63 | 203.06 | 155.02 | 59.11 | 11.46 | 8.28 | Upgrade |
Operating Expenses | 31,280 | 18,867 | 11,493 | 8,176 | 5,402 | 4,222 | Upgrade |
Operating Income | 27,704 | 23,667 | 28,026 | 25,600 | 18,226 | 12,327 | Upgrade |
Interest Expense | -304.57 | -263.43 | -60.28 | -13.3 | -521.47 | -58.16 | Upgrade |
Interest & Investment Income | 1,312 | 1,796 | 2,439 | 1,074 | 158.26 | 18.18 | Upgrade |
Earnings From Equity Investments | -215.7 | - | - | -311.08 | -327.99 | - | Upgrade |
Currency Exchange Gain (Loss) | -193.99 | 1,625 | 200.64 | 461.34 | 304.74 | -184.63 | Upgrade |
Other Non Operating Income (Expenses) | -7,720 | -8,037 | 2,103 | 129.56 | -2,107 | 34.9 | Upgrade |
EBT Excluding Unusual Items | 20,582 | 18,788 | 32,708 | 26,941 | 15,733 | 12,138 | Upgrade |
Gain (Loss) on Sale of Investments | 182.31 | 87.62 | 41.03 | 639.04 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 109.12 | 592.74 | -8.52 | -81.04 | - | -3.4 | Upgrade |
Asset Writedown | - | - | - | -28.02 | -1,565 | - | Upgrade |
Other Unusual Items | -1,804 | -1,804 | - | - | - | - | Upgrade |
Pretax Income | 19,069 | 17,664 | 32,740 | 27,471 | 14,168 | 12,134 | Upgrade |
Income Tax Expense | -1,511 | 153.09 | 5,318 | 6,763 | 3,495 | 2,431 | Upgrade |
Earnings From Continuing Operations | 20,580 | 17,510 | 27,422 | 20,708 | 10,673 | 9,703 | Upgrade |
Minority Interest in Earnings | -4,371 | -3,359 | -1,841 | 428.96 | 51.68 | - | Upgrade |
Net Income | 16,209 | 14,151 | 25,581 | 21,137 | 10,725 | 9,703 | Upgrade |
Net Income to Common | 16,209 | 14,151 | 25,581 | 21,137 | 10,725 | 9,703 | Upgrade |
Net Income Growth | -19.01% | -44.68% | 21.02% | 97.09% | 10.53% | 72.55% | Upgrade |
Shares Outstanding (Basic) | 57 | 57 | 58 | 57 | 52 | 50 | Upgrade |
Shares Outstanding (Diluted) | 64 | 60 | 61 | 57 | 52 | 50 | Upgrade |
Shares Change (YoY) | 5.97% | -0.28% | 5.64% | 10.68% | 3.82% | -2.75% | Upgrade |
EPS (Basic) | 282.57 | 249.20 | 444.85 | 371.84 | 207.02 | 194.39 | Upgrade |
EPS (Diluted) | 241.25 | 246.92 | 433.36 | 371.18 | 206.94 | 188.75 | Upgrade |
EPS Growth | -29.70% | -43.02% | 16.75% | 79.36% | 9.64% | 65.95% | Upgrade |
Free Cash Flow | -60,664 | -68,513 | -803.37 | 6,829 | -1,959 | 8,958 | Upgrade |
Free Cash Flow Per Share | -947.40 | -1133.97 | -13.26 | 119.07 | -37.80 | 179.45 | Upgrade |
Dividend Per Share | 50.000 | 50.000 | 70.000 | 70.000 | - | - | Upgrade |
Dividend Growth | -28.57% | -28.57% | - | - | - | - | Upgrade |
Gross Margin | 66.15% | 64.05% | 60.76% | 59.55% | 63.15% | 67.92% | Upgrade |
Operating Margin | 31.07% | 35.64% | 43.09% | 45.14% | 48.71% | 50.59% | Upgrade |
Profit Margin | 18.18% | 21.31% | 39.33% | 37.27% | 28.66% | 39.82% | Upgrade |
Free Cash Flow Margin | -68.04% | -103.17% | -1.23% | 12.04% | -5.24% | 36.76% | Upgrade |
EBITDA | 31,447 | 26,937 | 30,516 | 27,487 | 19,524 | 13,338 | Upgrade |
EBITDA Margin | 35.27% | 40.56% | 46.92% | 48.46% | 52.18% | 54.74% | Upgrade |
D&A For EBITDA | 3,744 | 3,270 | 2,490 | 1,887 | 1,298 | 1,010 | Upgrade |
EBIT | 27,704 | 23,667 | 28,026 | 25,600 | 18,226 | 12,327 | Upgrade |
EBIT Margin | 31.07% | 35.64% | 43.09% | 45.14% | 48.71% | 50.59% | Upgrade |
Effective Tax Rate | - | 0.87% | 16.24% | 24.62% | 24.67% | 20.04% | Upgrade |
Advertising Expenses | - | 1,045 | 230.71 | 228.49 | 32.22 | 13.29 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.